Atlas of Diagnostic Pathology in Nonhuman Primates

The Atlas of Diagnostic Pathology in Nonhuman Primates offers the first extensively illustrated collection of classic lesions in nonhuman primate diseases and pathological conditions, compiled by an international team of expert contributors. Organized by infectious and noninfectious conditions, the atlas comprehensively covers viral, bacterial, fungal, and parasitic diseases, as well as nutritional, toxic, and metabolic causes, and genetic, age-related, neoplastic, and noninfectious inflammatory conditions. Since nonhuman primates are an indispensable resource for efficacy and safety evaluation of novel therapeutic strategies targeting clinically important human diseases, research with monkeys is critical to understand how to prevent and treat emerging infectious diseases such as Zika virus disease, Ebola, Middle East Respiratory Syndrome (MERS), COVID-19/SARS-CoV-2/coronavirus, pandemic flu, and many more. This book is intended to serve veterinary practitioners in university facilities, zoos, biotechnological and pharmaceutical companies, as well as clinicians, researchers, and students engaged in nonhuman primate research.

 

Andrew D. Miller, DVM, Dipl. ACVP, is an Associate Professor of Pathology in the Section of Anatomic Pathology in the Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, USA. He focuses primarily on diagnostic pathology, comparative animal models of disease, and residency training, and has a diverse background in veterinary anatomic pathology, including nonhuman primate infectious disease and tumor pathobiology, comparative neuropathology, and veterinary diagnostic pathology. His current research interests include studying the pathogenesis and molecular targets of intracranial neoplasia, canine soft tissue sarcoma, focusing on aberrant protein expression as assessed by molecular, immunohistochemical, and image analysis. Additional research interests include understanding the role of tumor-associated inflammation in disease progression and prognosis in the dog.